[BREAKING] Hemerion obtains the FDA clearance for its next US clinical trial

Patients enrollment successfully completed

The enrollment phase of the clinical trial INDYGO is successfully completed, after only one year. During this study sponsored by the University Hospital of Lille (France) and with  Pr. N. Reyns as the Principal Investigator, 10 patients included from may 2017 to June 2018 have been treated with the Hemerion’s technology.